PVSRIPO in Combination With Nivolumab in Melanoma

Condition:   Melanoma Interventions:   Biological: PVSRIPO;   Drug: Nivolumab Sponsors:   Darell D. Bigner, MD, PhD;   Duke University;   Istari Oncology, Inc.;   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials